Route-dependent systemic and local immune effects following exposure to solutions prepared from titanium dioxide nanoparticles

References

• Anderson, P. K., Woolhiser, M. R., Rase, J. M., and Holsapple, M. P. 2003. Integration of primary irritation with the LLNA. The Toxicologist 72:492
   Google Scholar
• Anderson, S. E., Siegel, P. D., and Meade, B. J. 2011. The LLNA: A brief review of recent advances and limitations. J. Allergy 2011:424203
   PubMedGoogle Scholar
• Arys, A., Philippart, C., Dourov, N., et al. 1998. Analysis of titanium dental implants after failure of osseointegration: Combined histological, electron micro-scopy, and X-ray photoelectron spectroscopy approach. J. Biomed. Mater. Res. 43:300–312
   PubMed Web of Science ®Google Scholar
• Ashby, J., and Tennant, R. W. 1991. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257:229–306
   PubMed Web of Science ®Google Scholar
• Auttachoat, W., Chitsomboon, B., Peachee, V. L., et al. 2004. Immunomodulation by Don Din Daeng (Aeginetia indica Roxb.) extracts in female B6C3F1 mice: II. Humoral immunity, innate immunity and hematology. Int. Immunopharmacol. 4:1381–1390
   PubMed Web of Science ®Google Scholar
• Baan, R., Straif, K., Grosse, Y., et al. 2006. Carcinogenicity of carbon black, titanium dioxide, and talc. Lancet Oncol. 7:295–296
   PubMed Web of Science ®Google Scholar
• Borm, P. J., Robbins, D., Haubold, S., et al. 2006. The potential risks of nanomaterials: A review carried out for ECETOC. Part. Fibre Toxicol. 3:11
   PubMed Web of Science ®Google Scholar
• Brien, W.W., Salvati, E. A., Betts, F., et al. 1992. Metal levels in cemented total hip arthroplasty. A comparison of well-fixed and loose implants. Clin. Orthoped. Related Res. 264:66–74
   Google Scholar
• Buly, R. L., Huo, M. H., Salvati, E., et al. 1992. Titanium wear debris in failed cemented total hip arthroplasty. An analysis of 71 cases. J. Arthroplasty 7:315–323
   PubMedGoogle Scholar
• CEC (Commission of the European Communities). 1995. Commission directive 95/45/EC of 26 July 1995 laying down specific purity criteria concerning colors for use in foodstuffs. Available online at: http://ec.europa.eu/food/fs/sfp/addit_flavor/flav13_en.pd [last accessed 29 July 2013]
   Google Scholar
• Cedarvall, T., Lynch, I., Lindman, S., et al. 2007. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. USA 104:2050–2055
   PubMed Web of Science ®Google Scholar
• Cho, W. S., Kang, B. C., Lee, J. K., et al. 2013. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part. Fibre Toxicol. 10:9
   PubMed Web of Science ®Google Scholar
• Cunningham, B. W., Orbegoso, C. M., Dmitriev, A. E., et al. 2002. The effect of titanium particulate on development and maintenance of a postero-lateral spinal arthrodesis: An in vivo rabbit model. Spine 27:1971–1981
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia, M. A., Germolec, D. R., and Weaver, J. L. 2009. Evaluation of nanoparticle immunotoxicity. Nat. Nanotechnol. 4:411–414
   PubMed Web of Science ®Google Scholar
• Dooley, A., Gao, B., Bradley, N., et al. 2006. Abnormal nitric oxide metabolism in systemic sclerosis: Increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology (Oxford) 45:676–684
   PubMed Web of Science ®Google Scholar
• Duan, Y., Liu, J., Ma, L., et al. 2010. Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials 31:894–899
   PubMed Web of Science ®Google Scholar
• EFSA (European Food Safety Authority). 2004. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food on a request from the Commission related to the safety in use of rutile titanium dioxide as an alternative to the presently permitted anatase form. Available online at: http://efsa.europa.eu/en/efsajournal/doc/163.pdf [last accessed 9 September 2013]
   Google Scholar
• Furukawa, F., Doi, Y., Suguro, M., et al. 2010. Lack of skin carcinogenicity of topically applied titanium dioxide nanoparticles in the mouse. Food Chem. Toxicol. 49:744–749
   PubMed Web of Science ®Google Scholar
• Gad, S. C., Dunn, B. J., Dobbs, D. W., et al. 1986. Development and validation of an alternative dermal sensitization test: The mouse ear-swelling test (MEST). Toxicol. Appl. Pharmacol. 84:93–114
   PubMed Web of Science ®Google Scholar
• Gamer, A. O., Leibold, E., and van Ravenzwaay, B. 2006. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol. In Vitro 20:301–307
   PubMed Web of Science ®Google Scholar
• Gerhardt, L. C., Jell, G. M., and Boccaccini, A. R. 2007. Titanium dioxide (TiO2) nanoparticles filled poly(D,L-lactid acid) (PDLLA) matrix composites for bone tissue engineering. J. Mater. Sci. Mater. Med. 18:1287–1298
   PubMed Web of Science ®Google Scholar
• Greenacre, S. A., Rocha, F. A., Rawlingson, A., et al. 2002. Protein nitration in cutaneous inflammation in the rat: Essential role of inducible nitric oxide synthase and polymorphonuclear leukocytes. Br. J. Pharmacol. 136:985–994
   PubMed Web of Science ®Google Scholar
• Hussain, S., Smulders, S., de Vooght, V., et al. 2012. Nano-titanium dioxide modulates the dermal sensitization potency of DNCB. Part. Fibre Toxicol. 9:15
   PubMed Web of Science ®Google Scholar
• IARC (International Agency for Research on Cancer). 2006. Monographs on the evaluation of carcinogenic risks to humans. Carbon Black, Titanium Dioxide and Non-Asbestiform Talc. Vol 93. Geneva: World Health Organization
   Google Scholar
• Jani, P. U., McCarthy, D. E., and Florence, A. T. 1994. Titanium Dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int. J. Pharmaceut. 105:157–168
   Web of Science ®Google Scholar
• Jerne, N. K., and Nordin, A. A. 1963. Plaque formation in agar by single antibody-producing cells. Science 140:405–406
   Web of Science ®Google Scholar
• Kawabata, T. T., Babcock, L. S., Gauggel, D. L., et al. 1995. Optimization and validation of an ELISA to measure specific guinea pig IgG1 antibody as an alternative to the in vivo passive cutaneous anaphylaxis assay. Fundam. Appl. Toxicol. 24:238–246
   PubMedGoogle Scholar
• Lademann, J., Weigmann, H., Rickmeyer, C., et al. 1999. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol. Appl. Skin Physiol. 12:247–256
   PubMedGoogle Scholar
• Li, N., Duan, Y., Hong, M., et al. 2010. Spleen injury and apoptotic pathway in mice caused by titanium dioxide nanoparticules. Toxicol. Lett. 195:161–168
   PubMed Web of Science ®Google Scholar
• Liao, C. M., Chiang, Y. H., and Chio, C. P. 2008. Model-based assessment for human inhalation exposure risk to airborne nano/fine titanium dioxide particles. Sci. Total Environ. 407:165–177
   PubMed Web of Science ®Google Scholar
• Lu, N., Zhu, Z., Zhao, X., et al. 2008. Nano titanium dioxide photo-catalytic protein tyrosine nitration: A potential hazard of TiO2 on skin. Biochem. Biophys. Res. Commun. 370:675–680
   PubMed Web of Science ®Google Scholar
• Ma-Hock, L., Strauss, V., Treumann, S., et al. 2013. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoparticles, and low surface carbon black. Part. Fibre Toxicol. 10:23
   PubMed Web of Science ®Google Scholar
• Mavon, A., Miquel, C., Lejeune, O., et al. 2007. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol. Physiol. 20:10–20
   PubMed Web of Science ®Google Scholar
• Miyauchi, T., Yamada, M., Yamamoto, A., et al. 2010. The enhanced characteristics of osteoblast adhesion to photofunctionalized nanoscale TiO2 layers on biomaterials surfaces. Biomaterials 31:3827–3839
   PubMed Web of Science ®Google Scholar
• Monopoli, M. P., Åberg, C., Salvati, A., and Dawson, K. A. 2012. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 7:779–786
   PubMed Web of Science ®Google Scholar
• Mueller, N. C., and Nowack, B. 2008. Exposure modeling of engineered nanoparticles in the environment. Environ. Sci. Technol. 42:4447–4453
   PubMed Web of Science ®Google Scholar
• Müller, K., and Valentine-Thon, E. 2006. Hypersensitivity to titanium: Clinical and laboratory evidence. NeuroEndocrinol Lett. 27:31–35
   PubMed Web of Science ®Google Scholar
• National Cancer Institute, Carcinogenesis, Technical Report Series No.97. 1979. Bioassay of titanium dioxide for possible carcinogenicity (CAS No. 3463-67-7) NCI-CG-TR-97. Available online at: http://ntp.niehs.gov/ntp/htdocs/LT_rpts/tr097.pdf [last accessed 10 Sep 2013]
   Google Scholar
• Newman, M. D., Stotland, M., and Ellis, J. I. 2009. The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens. J. Am. Acad. Dermatol. 61:685–692
   PubMed Web of Science ®Google Scholar
• NIH. 1999. The murine local lymph node assay: A test method for assessing the allergic contact dermatitis potential of chemicals/compounds. NIH Publication No. 99-4494
   Google Scholar
• NMI (National Measurement Institute). 2012. XRD Phase Analysis of TiO2 Sunscreens. Australian Government, NMI. Available from: http://libcloud.s3.amazonaws.com/93/5a/1/2746/NMI-report-XRD-anatase.pdf [last accessed 29 July 2013]
   Google Scholar
• Olmos, A., Giner, R. M., Recio, M. C., et al. 2007. Effects of plant alkylphenols on cytokine production, tyrosine nitration and inflammatory damage in the efferent phase of contact hypersensitivity. Br. J. Pharmacol. 152:366–373
   PubMed Web of Science ®Google Scholar
• Pflucker, F., Wendel, V., Hohenberg, H., et al. 2001. The human stratum corneum layer: An effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide. Skin Pharmacol. Appl. Skin Physiol. 14:92–97
   PubMedGoogle Scholar
• Ratner, B. D. 2004. Biomaterials Science: An Introduction to Biomaterials in Medicine, Chapter 3, 2nd ed (Ratner, B. D., Hoffman, A. S., Schoen, F. J., and Lemons, J. E., Eds.). London: Elsevier Academic Press
   Google Scholar
• Sadrieh, N., Wokovich, A. M., Gopee, N.V., et al. 2010. Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO2 particles. Toxicol. Sci. 115:156–166
   PubMed Web of Science ®Google Scholar
• SCCP (Scientific Committee on Consumer Products). 2007. SCCP/1147/07: Opinion on safety of nanomaterial in cosmetic products. Adopted by the SCCP after the public consultation on the 14th Plenary of 18 December 2007. Available online at: http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_123.pdf [last accessed 10 Sep 2013]
   Google Scholar
• Schulz, J., Hohenberg, H., Pflucker, F., et al. 2002. Distribution of sunscreens on skin. Adv. Drug Deliv. Rev. 54:S157–S163
   PubMed Web of Science ®Google Scholar
• Shelby, M. D. 1988. The genetic toxicity of human carcinogens and its implications. Mutat. Res. 204:3–15
   PubMed Web of Science ®Google Scholar
• Shelby, M. D., and Zeiger, E. 1990. Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests. Mutat. Res. 234:257–261
   PubMed Web of Science ®Google Scholar
• Shin, J. A., Lee, E. J., Seo, S. M., et al. 2010. Nanosized titanium dioxide enhanced inflammatory responses in the septic brain of mouse. Neuroscience 165:445–454
   PubMed Web of Science ®Google Scholar
• Sigma-Aldrich. 2009. Certificate of Analysis: Titanium(IV) oxide, anatase, nanopowder, <25 nm particle size. St. Louis, MO: Sigma-Aldrich
   Google Scholar
• Smith, C. M., Roy, T. D., Bhalkikar, A., et al. 2010a. Engineering a titanium and polycaprolactone construct for a biocompatible interface between the body and artificial limb. Tissue Eng. Part A 16:717–724
   PubMed Web of Science ®Google Scholar
• Smith, D. C., Smith, M. J., and White, K. L. Jr. 2010b. Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice. J. Immunotoxicol. 7:219–231
   PubMed Web of Science ®Google Scholar
• Smith, M. J., and White, K. L. Jr. 2010. Establishment and comparison of delayed-type hypersensivity models in the B6C3F1 mouse. J. Immunotoxicol. 7:308–317
   PubMed Web of Science ®Google Scholar
• Stokes, R., and Diffey, B. 1997. How well are sunscreen users protected? Photodermatol. Photoimmunol. Photomed. 13:186–188
   PubMed Web of Science ®Google Scholar
• Szabo, E., Virag, L., Bakondi, E., et al. 2001. Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity. J. Invest. Dermatol. 117:74–80
   PubMed Web of Science ®Google Scholar
• Temple, L., Kawabata, T. T., Munson, A. E., and White, K. L. Jr. 1993. Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 21:412–419
   PubMedGoogle Scholar
• TGA. 2006. A review of the scientific literature on the safety of nanoparticulate titanium dioxide or zinc dioxide in sunscreens. Australian Government, OTC Medicines Section. Available online at: http://www.tga.gov.au/npmeds/sunscreen-zotd.pdf [last accessed 10 Sep 2013]
   Google Scholar
• U.S. Food and Drug Administration (FDA). 2010. CFR-Code of Federal Regulations Title 21, Volume 1-Food and Drugs, Chapter 1-Food and Drug Administration. Department of Health and Human Services. Subchapter A-general, part 73- listing of color additives exempt from certification. Revised on April 1, 2010. 21 CFR73.575. Available online at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=73.575 [last accessed 10 Sep 2013]
   Google Scholar
• Walkey, C. D., Olsen, J. B., Guo, H., et al. 2012. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134:2139–2147
   PubMed Web of Science ®Google Scholar
• Wang, J., Zhou, G., Chen, C., et al. 2007. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 168:176–185
   PubMed Web of Science ®Google Scholar
• Weaver, J. L., Chapdelaine, J. M., Descotes, J., et al. 2005. Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions. J. Immunotoxicol. 2:11–20
   PubMedGoogle Scholar
• Weir, A., Westerhoff, P., Fabricius, L., et al. 2012. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 46:2242–2250
   PubMed Web of Science ®Google Scholar
• White, K. L., Musgrove, D. L., and Brown, R. D. 2010. The sheep erythrocyte T-dependent antibody response (TDAR). Methods Mol. Biol. 598:173--184
   Google Scholar
• Witt, K. L., Knapton, A., Wehr, C. M., et al. 2000. Micronucleated erythrocyte frequency in peripheral blood of B6C3F1 mice from short-term, prechronic, and chronic studies of the NTP carcinogenesis bioassay program. Environ. Mol. Mutagen. 36:163–194
   PubMed Web of Science ®Google Scholar
• Woolhiser, M. R., Hayes, B. B., and Meade, B. J. 1998. A combined murine local lymph node and irritancy assay to predict sensitization and irritancy potential of chemicals. Toxicol. Mech. Meth. 8:245–256
   Google Scholar
• World Health Organization. 1969. FAO Nutrition Meeting Report Series No. 46 A: Toxicological evaluation of some food colors, emulsifers, stabilizers, anti-caking agents, and certain other substances. Geneva: WHO/FOOD ADD/70.36
   Google Scholar